Upload
ifsbh
View
381
Download
1
Tags:
Embed Size (px)
Citation preview
How to develop a national advocacy campaign?
Maria BrandaoConsultant to Bayer HealthCare Pharmaceuticals
at Burson-Marsteller Brussels
IF Workshop, Brussels, 28 June 2011
1
What is advocacy?• Advocacy by an individual or by an advocacy group normally aims to influence publicpolicy and resource allocation decisions within political, economic, and social systems and institutions
• Advocacy can include many activities that a person or organisation undertakes including media campaigns, public speaking, commissioning and publishing research, polls, briefings, position papers, etc
Source: Wikipedia: http://en.wikipedia.org/wiki/Advocacy
2
What can YOU gain from advocacy?
• Public recognition, increased awareness of and mobilisation for your issue...
• ... Leading to POLICY CHANGE...
• ... that will improve in the LONG TERM the situation for your organisation and the issue you are defending
3
How can you start an advocacy campaign in your country?
The five step process
4
Step 1: Monitoring
Step 2: Information & Analysis
Step 3: Strategic Consideration
Step 4: Develop and key messages and communication tools
Step 5: Advocate: make noise
Development phase
Implementation phase
Five step process for an effective advocacy campaign
6
Monitoring:What’s happening?Who’s doing what? How canyou benefit from or shape the environment toreach your objectives?
Tips: Mozilla Firefox, Google alerts, etc
Information and Analysis:Map stakeholders and developments you canuse/leverage (e.g. Guidelines, policies, etc).Identify potential opportunities versuschallenges early enoughTips: make sure you get facts and figures ofinterest to your country
Strategic consideration:Develop your strategy based on the information& analysis, and set out objectives, actions,responsibility and timeline! (e.g. European andnational plans in key countries)
Tips: make sure you track down your activity asit will help you keep focused!
7
Develop key messages and other tools:Identify which stakeholders you will bereaching out to, what you will tell them and withwhich objective in mindDevelop messaging accordingly
Tips: use message houses to structure yourmessages and make sure you include evidence
Advocate: make some noiseReach out to stakeholders identified in step 2, set up a meeting and follow up accordingly on next steps (e.g. Establish collaborations, get them to speak up about your issue, discuss funding) Organise an event and generate media attention (e.g. Policy event or media luncheon) Disseminate communications tools widelyTips: Prepare, know what you’re asking each partner to do and be ready to give them something in return
Message House
8
Key Message 1
(Context)
Key Message 2
(Relevance)
Key Message 3
(Difference)
The Story in 30 seconds
Supporting facts and examples
Supporting facts and examples
Supporting facts and examples
Case study: The EU NTD advocacy campaign
Objectives1. Move the debate on NTD prevention up the EU policy agenda and from the food to the public health arena
2. Develop partnerships with credible 3rd parties to improve the visibility of your organisation and the NTD issue
3. Secure the inclusion of NTD prevention in healthpolicy programmes (e.g. rare diseases) and education
Case study: The EU NTD advocacy campaign –RESULTS at regional level
Improved visibility of the NTD issue and debate being held in public health arena Dissemination of key messages via postcard campaign Dissemination of 2000 copies of the report to policy makers, healthcare community (e.g. congresses) and online (e.g. Commissionwebsite)
Members of the EP published questions and Commission’s Heath Department (DG SANCO) expressed commitment to NTD prevention
Secured partnerships and political support to be leveraged if/when needed (e.g. with MEPs, EFCNI, etc.)
Secured policy successes that will last in the longterm NTD prevention to be included in the EU Rare Disease Road Map Maternal health dimension in EP report on health inequalities
10
Coming up soon...
11
Strengthening partnerships with importantpartners and exploring activities of mutualbenefit not only at EU but also at national level
Publication of studies on NTDs in medicaljournals
What can you do?Publish them online and disseminate them toyour contacts
Publication of the 2nd report on NTDs
What can you do?Coming up later today
12
Any questions?
Thank you for listening!
How to leverage advocacy activities and the report at national level?
13
Maria BrandaoConsultant to Bayer HealthCare Pharmaceuticals
at Burson-Marsteller Brussels
IF Workshop, Brussels, 28 June 2011
About the 2nd report on NTDs
1. Partners
2. Concept: focus on policy impacting NTD prevention from a horizontal perspective
3. Key messages1. Little has happened in the last 20 years and no progress
since the first NTD report2. More can be done in the area of prevention14
Led the drafting and sponsored (MC and Bayer)
Supported with dataEndorsed (partly or fully)
15
About the 2nd report on NTDs
Our call to Action1. Adopt and align recommendations of folate acid intake with WHO standard and monitor their
implementation by healthcare professionals
2. Raise awareness in women of childbearing age and the healthcare community (for example, include messages on prevention of NTD and the importance of folate levels in health and sexual education curricula)
3. Ensure NTD prevention is included in related policy (e.g. Rare Disease, Health Inequalities, Nutrition, etc)
4. Continue funding European registries and push for more and better collection of comparable data
5. Investigate further the costs of food fortification and supplementation strategies
6. Explore new methods to raise folate levels of women of childbearing age including the value of food fortification and supplementation strategies
16
How to create some noise about the report?
How can you leverage the 2nd report on NTDs at national level?
17
Get the report adapted to your nationalsituation, translate it in your language & secureforeword by key national personality (policymaker, Key Opinion Leader, etc.)
Use it as a point of entry to discuss the issuewith policy makers, Key Opinion Leaders andother 3rd party organisations and identify yournational champion to ensure he/she voices yourkey messages!
Disseminate it online, in your publications andask partners and policy makers to do the same(e.g. Post it on Ministry of Health website)
18
Disseminate it (e.g. at stands, in meeting packs,etc.) and secure speaking opportunities at yourpartners’ congresses to present it
Work with a Key Opinion Leader to exploreauthoring a feature article
How can you leverage the 2nd report on NTDs at national level?
Collaborate with national partners on a launchevent with media campaign to present reportfindings
19
Any questions?
Thank you for listening!